China delays the approval of 35 billion dollars in American flea fusion in the middle of the commercial war of Donald Trump
Unlock the publisher’s digest free
Roula Khalaf, editor -in -chief of the FT, selects her favorite stories in this weekly newsletter.
A merger of the US semiconductor industry of $ 35 billion is delayed by the antitrust regulator in Beijing, after Donald Trump has tightened china exports against China in a decision that exacerbated trade tensions between the two largest economies in the world.
The administration of the state of China for market regulations has postponed its approval of the agreement proposed between Synopsys, a manufacturer of flea design tools and the developer of engineering software Ansys, according to two people knowing the issue.
The transaction between American groups, which received the blessing of the authorities in the United States and Europe, had already entered the last stage of the Samr approval process and is expected to be completed by the end of this month, the people said.
The delay arises while Washington has evolved to ban sales of flea design software by American companies, including Synopsys, in China at the end of May. This decision contributed to the complexity of the China approval process for this agreement, according to a person who knows the situation.
The person added that approval, while taking more time than expected, could still happen if Synopsys could submit solutions that responded to the concerns of the Chinese regulator.
However, another person knowing the case said that the Samr approval process had recently been extended from their original schedule of 180 days due to the complexity of the agreement itself, rather than being directly linked to the current trade war.
During the last call on the results of the company on May 28, the director general of Synopsys, Sassine Ghazi, said that the company “worked in cooperation and actively merchant with Samr to guarantee regulatory authorization in China”, and that it expected to conclude the agreement “in the first half of this year”.
The transactions agreement includes a “Drop Dead clause of January 15, 2026”, according to the files of the company.
Synopsys refused to comment. Ansys did not respond to a request for comments. A call made to Samr outside regular working hours has not received an answer.
This decision comes in the midst of American commercial talks. This week, Trump said the two parties had entered into an agreement in London to restore the truce of the trade war reached in Geneva in May, when the United States and China have considerably reduced the high level of tariffs they had imposed.
A senior White House official said this week that Trump could facilitate technological export controls to China if Beijing agreed to accelerate rare land shipments.
There have also been signs of potential relaxation of the American ban on selling flea design tools. Synopsys, which previously stopped all sales to Chinese customers, has restarted the sale of intellectual property and equipment, while so -called electronic design software tools are always restricted, according to a person with direct knowledge of the issue.
Synopsys’ tools and intellectual property, based on Silicon, are used by flea manufacturers, including NVIDIA and Intel to help design and test their processors.
The semiconductor designer has increased in recent years while large technological companies, including Microsoft, Google, Meta and Amazon, strive to create more of their own chips, in particular to manage artificial intelligence systems in the cloud.
Ansys, which is based in Pennsylvania and has its origins in structural analysis tools, manufactures engineering simulation software used in industries, cars and construction to health care and defense.
Additional report by Michael Acton in San Francisco and Ivan Levingston in London
